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journal home page: www.elsevier .com/ locat e/euprotAt the turn of the millennium, the analysis of proteins in a
sample by mass spectrometry experienced a series of technology
developments that greatly advanced its analytic reach and power
[1]. The key improvements were peptide-centric methods that
focused on peptides as the primary analyte rather than the much
more diverse and cumbersome proteins that are the biological
entity of interest, and the ever faster cycling and increasingly
precise mass spectrometers that allowed the highly complex
peptide samples to be analysed sufﬁciently quickly and accurately
[2]. It is however, worth noting that these developments were
strongly supported by already established bioinformatics infra-
structure, most notably the availability of reliable protein sequence
databases [3], and of automated search engines that could match
an experimental fragmentation spectrum to a peptide sequence
obtained after proteolytic digest of these protein sequence
databases [4]. Indeed, without these search engines or the
databases these rely on, the ﬁeld would have been incapable of
handling the vast amounts of data generated by the new
approaches and instruments.
Importantly, the much higher throughput achieved from
roughly the year 2000 onwards, saw an increasing amount of
scrutiny aimed at the results obtained. While few people
questioned the data themselves (exhaustive quality control ofAbbreviations: GPMDB, Global Proteome Machine Database; PRIDE, Proteomics
Identiﬁcations Database; MIAPE, minimal information about a proteomics
experiment; ESF, European Science Foundation.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).the data has only recently become a topic of focused interest, see
below), many researchers started to wonder about the reliability of
the hundreds, and then thousands of peptide identiﬁcations that
appeared at the end of each analytical run. In response, several
papers came out in rapid succession, seeking to understand the
behaviour of the existing algorithms on these large bodies of data,
and looking for ways to ﬁlter out correct identiﬁcations from
spurious ones [5–7]. At the same time, the central importance of
search engines in shotgun proteomics was further conﬁrmed by
the publication of several additional algorithms such as OMSSA [8]
and X!Tandem [9]. These tools added to a growing repertoire of
software that could be used to provide ever more sophisticated
analyses of the acquired data.
However, despite the increasing sophistication of proteomics
techniques and identiﬁcation software, the ever growing number
of identiﬁcations obtained from a single run was received quite
sceptical even within the ﬁeld itself. On the other hand, it also
became clear that the wealth of data generated was direly in need
of standardization, structured management, and dissemination for
re-use. In order to address these two seemingly independent
issues, data validation on the one hand, and data management and
dissemination on the other hand, Prince et al. [10] were ﬁrst to
state the need for a public proteomics data repository. In their
paper, they also introduced an open, online system for storing and
sharing proteomics data ﬁles. Almost simultaneously, Craig et al.
published the Global Proteome Machine Database (GPMDB)
system that consisted of a complete data processing pipeline
based on the X!Tandem search engine, connected to a relational
database to house the results [11]. The next year, Desiere et al. [12]
published the PeptideAtlas system that also featured a processing
pipeline feeding into a database, while my collaborators and I
published the Proteomics Identiﬁcations Database (PRIDE) as a
submission-driven, structured data repository [13] (seeics Association (EuPA). This is an open access article under the CC BY-NC-ND license
L. Martens / EuPA Open Proteomics 11 (2016) 42–44 43Supplementary Material for the original grant application to
develop the PRIDE database, submitted in June 2003).
While all very similar in underlying concept, these ﬁve efforts at
building a repository had different goals at the start. On the one
hand, the system developed by Prince et al. shared the true
repository focus of PRIDE, with both systems intended for the
accurate dissemination of original data and associated results. On
the other hand, PeptideAtlas and GPMDB were more focused on re-
use of the data from the start. PeptideAtlas placed a strong focus on
re-using the reprocessed public data as a means to annotate the
(human) genome, while the GPMDB data were used to discover
proteotypic peptides [14] and to build spectral libraries [15]. Since
then, several additional repositories have been developed [16–18],
and some have also been lost again [19,20]. The key databases have
however, been uniﬁed under the ProteomeXchange umbrella,
allowing data submission and retrieval to be carried out in a clearly
delineated, straightforward way [21].
It is particularly worth noting that all repositories have
embraced the concept of data re-use that was so central to the
existence of PeptideAtlas and the GPMDB from their inception. For
instance, the PRIDE repository now features its own in-house
generated spectral libraries [22], and data re-use has enabled
researchers to perform an indirect type of crowd-sourcing of data
from across the entire proteomics ﬁeld [23]. Tools and web services
to access these online data, such as PRIDE Inspector [24], pride-
asap [25], the PRIDE REST service [26] and PeptideShaker [27] have
also substantially lowered the threshold to data re-use, allowing
any interested user to explore the publicly available data in any
way imaginable. The speciﬁc role of proteomics as a genome
annotation source has also matured over the years, with UniProt
listing cross-references to, and annotations from, PeptideAtlas and
PRIDE, amongst many other sources. Moreover, dedicated analysis
pipelines [28] have recently enabled proteomics data from PRIDE
to serve as direct annotation sources for databases describing novel
genome features such as long non-coding RNAs [29,30] and small
open reading frames [31]. Indeed, the re-analysis of these publicly
available proteomics data now attracts substantial research efforts,
and this trend is likely to increase as ever more possible forms of
data re-use are put in place (see Vaudel et al. [32] for a review of the
possibilities and opportunities).
It should be noted however, that the key issue that hampers
proteomics data re-use is the lack of sufﬁcient metadata reported
along with the original data and results. Indeed, despite the early
formulation of the necessary minimal reporting requirements in
the form of the Minimal Information About a Proteomics
Experiment (MIAPE) [33] and the development of MIAPE-ready
standard data formats (notably mzML [34], mzIdentML [35], and
mzQuantML [36]), the level of annotation of public data sets
remains suboptimal [37]. It should however, be noted that
curatorial efforts at the PRIDE database (the most widely used
point of submission in the ProteomeXchange consortium) have
helped increase the level of core annotation substantially [37]. It is
expected that further automation of data submission pipelines
(starting from PRIDE Converter in 2009 [38], PRIDE Converter 2 in
2012 [39], and supplemented with the ProteomeXchange submis-
sion tool in 2014 [21]) will also make it ever easier for submitters to
provide all relevant information along with their original data and
results.
The future for public proteomics data dissemination is certainly
bright, especially because data sharing is strongly encouraged, and
increasingly even mandated by important funders such as the
Wellcome Trust, the NIH, and the European Commission on the one
hand, and by leading journals in the ﬁeld on the other hand. Along
with this ever more solid basic role in the ﬁeld, public data will
continue to evolve. A major new development in the foreseeable
will undoubtedly be the integration of quality control metricsalong with the submitted data. Indeed, the ﬁeld has shown an
increasing awareness of the importance of quality control over the
past few years, with a very strong effort by Rudnick et al. [40] in
2010 as a clear milestone towards much more global quality
assessment and assurance. Simultaneously, a dedicated, European
Science Foundation (ESF) funded workshop on quality control in
proteomics in Cambourne, UK in 2010 [41] delivered several
relevant papers in the next year [42]. These initial efforts were
followed up by several important publications detailing ways in
which to automate the gathering of quality control parameters
[43–47], and perspectives on the importance of establishing robust
quality control in the ﬁeld, notably with an eye to clinical
applications [48,49]. It should be further noted that quality control
at the level of the repository [50] and within public data [25,51]
had also been taken up by this time. The ﬁnal piece of the quality
control puzzle has been delivered by the formulation of a generic
standard for reporting quality control metrics, in the form of qcML
[52], its associated programmatic access libraries [53], and
compatible, automated workﬂows [46]. It is, therefore, only a
matter of time before submissions to public repositories will either
need to be accompanied by quality control parameters at the time
of submission, or will have a standard set of quality control metrics
calculated automatically after submission.
Public data have clearly come a long way in proteomics, and the
current availability of data already provides highly exciting
opportunities for re-use. It is noteworthy that the original focus
of data validation has thus been superseded with a much more
positive outlook: that of the promise of data re-analysis. With ever
better metadata annotation, the reach of such re-analyses will
moreover only become wider. It can, therefore, be expected that
the term in silico proteomics will soon become commonplace, and
when this happens, it will be a crucial and highly useful milestone
for the ﬁeld at large.
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